Hematological Incidies May Predict Oxidative Stress in Patients with ST-segment Elevation Myocardial Infarction
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2023
DOI: 10.5543/tkda.2022.37011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2023. Verfasst von Belma Kalayc und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zonguldak Bulent Ecevit University, School of Medicine, Department of Cardiology, Zonguldak, T��rkiye. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Zonguldak Bulent Ecevit University, School of Medicine, Department of Cardiology, Zonguldak, T��rkiye.
- Zonguldak Bulent Ecevit University, Faculty of Pharmacy, Department of Biochemistry, Zonguldak, T��rkiye.
- Zonguldak Ataturk State Hospital, Department of Cardiology, Zonguldak, T��rkiye.
Zitieren
APA
Kalayc, B., Hamamc O Lu, A. C., & Kalayc, S. L. (2023). Hematological Incidies May Predict Oxidative Stress in Patients with ST-segment Elevation Myocardial Infarction. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. https://doi.org/10.5543/tkda.2022.37011
Vancouver
Kalayc B, Hamamc O Lu AC, Kalayc SL. Hematological Incidies May Predict Oxidative Stress in Patients with ST-segment Elevation Myocardial Infarction. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2023. doi:10.5543/tkda.2022.37011
BibTeX
@article{Kalayc2023,
author = {Kalayc, Belma and Hamamc O Lu, Ayse Ceylan and Kalayc, S Leyman},
title = {Hematological Incidies May Predict Oxidative Stress in Patients with ST-segment Elevation Myocardial Infarction},
journal = {Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology},
year = {2023},
doi = {10.5543/tkda.2022.37011}
}
EUVIMED